Skip to main content
Clinical Effectiveness Group

JSNA

Joint Strategic Needs Assessment (JSNA) reports are used by local authorities and NHS commissioners to understand the health, care and wellbeing needs of the local community. 

JNSA reports show a snapshot in time. We produce them annually using data extracted from EMIS on 1 April. The reports are published after the April extraction date, once we have analysed the data. 

The reports cover the whole NHS North East London region, which includes Barking and Dagenham, City and Hackney, Havering, Newham, Redbridge, Tower Hamlets and Waltham Forest. 

JSNA reports 2024

Click a stage to download the report:

Prevalence reporting

Locality reports, with detail at network and practice level. Shows register size, crude prevalence and age standardised prevalence for major disease conditions, including: 

  • Asthma
  • Atrial Fibrillation
  • Chronic Kidney Disease
  • Diabetes
  • Hypertension
  • Mental Health (serious mental illness)

See the index (below) for a full list of conditions.

Prevalence reporting

Locality reports, with detail at network and practice level. Shows register size and crude prevalence for conditions, including:

  • Epilepsy
  • Learning Disabilities
  • Multiple Sclerosis
  • Osteoporosis
  • Palliative Care
  • Parkinson's Disease
  • Rheumatoid Arthritis 

See the index (below) for a full list of conditions.

Prevalence reporting

Locality reports, with detail at network and practice level. Shows register size and crude prevalence for diseases and conditions, including:

  • Cancer
  • Eating disorders
  • Homelessness
  • Housebound
  • Obesity
  • Psoriasis
  • Substance Misuse

See the index (below) for a full list of conditions.

Demographic reporting

At locality level, showing patient counts by register for a wide range of diseases and conditions. Demographic information:

  • Age band (10-year)
  • Ethnic group recording (5 ethnic categories)
  • Sex / gender
  • Deprivation – quintiles using IMD score (Index of Multiple Deprivations)

Demographic reporting

At locality level, showing patient counts by register for Coronary Heart Disease, Diabetes, and Stroke. Each with sub-populations for current smokers, blood pressure level, and blood indicator level (e.g. cholesterol, HbA1c). Demographic information:

  • Age band (10-year)
  • Ethnic group recording
  • Sex / gender
  • Deprivation – quintiles using IMD score (Index of Multiple Deprivations)

Quick reference index

These are all of the conditions covered by the JSNA, and the stage reports that contain information about them:

Asthma   1a, 2
Atrial Fibrillation   1a
Cancer   1c
Chronic Kidney Disease (CKD)   1a
Chronic Obstructive Pulmonary Disease (COPD)   1a, 2
Coronary Heart Disease (CHD)   1a, 2, 3
Current Smoker   2
Dementia   1a, 2
Depression   1a
Diabetes   1a, 2, 3
Diabetes - Type 1   2
Diabetic Retinal Screening   1b
Eating disorders   1c
Epilepsy   1b, 2
Heart Failure   1a
Homelessness   1c
Housebound   1c
Human Immunodeficiency Virus (HIV)   1b
Hypertension   1a, 2
Learning Disabilities   1b, 2
Mental Health   1a
Motor Neurone Disease   1b, 2
Multiple Sclerosis   2
Obesity   1c, 2
Osteoporosis   1b
Palliative Care   1b
Parkinson's Disease   1b, 2
Peripheral Arterial Disease (PAD)   1a, 2
Psoriasis   1c
Rheumatoid Arthritis   1b
Severe Mental Illness (SMI)   2
Stroke / Transient Ischaemic Attack   1a, 2, 3
Substance Misuse   1c

Archive

JSNA 2023 stage 1a [XLS 216KB]

Includes register size, crude prevalence and age standardised prevalence, broken down by locality and individual practice for: 

Asthma, atrial fibrillation, coronary heart disease, chronic kidney disease, chronic obstructive pulmonary disease, dementia, depression, diabetes, heart failure, hypertension, peripheral arterial disease, serious mental illness (mental health), stroke.

 

JSNA 2023 stage 1b [XLS 158KB]

Includes register size and crude prevalence, broken down by locality and individual practice for: 

Diabetes – retinal screening, eating disorders, epilepsy, HIV, homelessness, learning disabilities, motor neurone disease, multiple sclerosis, osteoporosis, palliative care, Parkinson's Disease, psoriasis, rheumatoid arthritis, substance misuse.

 

JSNA 2023 stage 2 [XLS 4,357KB]

Includes register size by sex, age, deprivation quintile, ethnicity, and the presence of specific further conditions, broken down by locality for: 

Asthma, coronary heart disease, stroke, learning disabilities, obesity, diabetes, hypertension, chronic obstructive pulmonary disease, serious mental illness (mental health), current smokers, epilepsy, multiple sclerosis, Parkinson's disease, diabetes - type 1, dementia, peripheral arterial disease.

 

JSNA 2023 stage 3 [XLS 10,019KB]

Includes number of patients meeting the different process measures for each condition, reported by sex, age, deprivation quintile, ethnicity, and the presence of specific further conditions. Broken down by locality for: 

Diabetes patients who are current smokers, or who have controlled cholesterol / blood pressure / blood sugar (HbA1c), or retinal screening done.  Stroke patients who are current smokers, or who have controlled cholesterol / blood pressure.  Coronary heart disease patients who are current smokers, or who have controlled cholesterol / blood pressure.

JSNA 2022 - Stage 1a [XLS 218KB]

Includes register size, crude prevalence and age standardised prevalence, broken down by locality and individual practice for: 

Active asthma, atrial fibrillation, coronary heart disease, chronic kidney disease, chronic obstructive pulmonary disease, dementia, depression, diabetes, heart failure, hypertension, peripheral arterial disease, serious mental illness, stroke. 

 

JSNA 2022 - Stage 1b [XLS 136KB]

Includes register size, crude prevalence and age standardised prevalence, broken down by locality and individual practice for: 

Diabetes – retinal screening, epilepsy, HIV, learning disabilities, multiple sclerosis, osteoporosis, palliative care, Parkinson’s disease, rheumatoid arthritis. 

 

JSNA 2022 - stage 2 [XLS 7,799KB]

Includes register size, crude prevalence and age standardised prevalence, broken down by locality and individual practice for: 

Active asthma, chronic obstructive pulmonary disease, coronary heart disease, dementia, diabetes (age 17+), diabetes type 1 (all ages), epilepsy, hypertension, learning disabilities, multiple sclerosis, obesity, Parkinson’s disease, peripheral arterial disease, serious mental illness, smokers, stroke/TIA. 

 

Back to top